Phase Ib/IIa Study of SLIT Cisplatin by Inhalation in the Treatment of Patients Wtih Relapsed/Progressive Osteosarcoma Metastatic to the Lung

Trial Profile

Phase Ib/IIa Study of SLIT Cisplatin by Inhalation in the Treatment of Patients Wtih Relapsed/Progressive Osteosarcoma Metastatic to the Lung

Completed
Phase of Trial: Phase I/II

Latest Information Update: 03 Aug 2017

At a glance

  • Drugs Cisplatin (Primary)
  • Indications Cancer metastases; Osteosarcoma
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Sponsors Insmed
  • Most Recent Events

    • 07 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Jul 2010 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov.
    • 24 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top